Results 71 to 80 of about 12,523 (206)
Treatment of invasive candidiasis with echinocandins [PDF]
SummaryBlood stream infections by Candida spp. represent the majority of invasive fungal infections in intensive care patients. The high crude mortality of invasive candidiasis remained essentially unchanged during the last two decades despite new treatment options that became available.
Andreas, Glöckner +3 more
openaire +2 more sources
Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris
Candida auris has simultaneously emerged on five continents as a fungal pathogen causing nosocomial outbreaks. The challenges in the treatment of C.
David S. Perlin +13 more
core +1 more source
Background. Candida tropicalis is a virulent fungal pathogen for which echinocandins are the primary therapy. Emergence of resistance to echinocandins of C. tropicalis carries potentially ominous therapeutic implications. Methods.
Maroun M. Sfeir +8 more
doaj +1 more source
Candida glabrata Isolated From Tubo‐Ovarian Abscess Cultures in Two Immunocompetent Patients
Persistent 7.3 × 5.8 cm TOA unresponsive to 4 weeks of antibiotic treatment and percutaneous drainage, growing Candida glabrata on cultures. ABSTRACT In this clinical case report, we present two immunocompetent patients with tubo‐ovarian abscesses (TOAs) that were positive for Candida glabrata.
Marlee Hirsch +6 more
wiley +1 more source
Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study
Objectives: We studied whether fluconazole or echinocandin treatment of Candida glabrata fungaemia results in superior outcomes. Methods: A multicentre, retrospective study was performed with 224 adult patients who received >= 5 days of therapy with ...
Eschenauer, Gregory A.;Carver, Peggy L.;Lin, Shu-Wen;Klinker, Kenneth P.;Chen, Yee-Chun;Potoski, Brian A.;Shields, Ryan K.;Clancy, Cornelius J.;Nguyen, Minh-Hong;Lam, Simon W. +1 more
core +1 more source
Epidemiology of Echinocandin Resistance in Candida [PDF]
Echinocandins are the newest antifungal agents approved for use in treating Candida infections in the US. They act by interfering with 1,3-β-D-glucan synthase and therefore disrupt cell wall production and lead to Candida cell death. There is no intrinsic resistance to echinocandins among Candida species, and isolates from historic collections archived
Nina T, Grossman +2 more
openaire +2 more sources
Candida (Candidozyma) auris is an emerging multidrug-resistant fungal pathogen capable of establishing persistent skin colonization, contaminating the environment, and causing nosocomial outbreaks associated with high mortality rates.
Fruzsina Kovács +11 more
doaj +1 more source
This review focuses on vulvovaginal candidiasis (VVC), examining its epidemiology, the pathogenesis of Candida albicans, and its relationships with vaginal microbiota. It comprehensively reviews probiotic‐based management strategies and their mechanisms of action, and concludes by discussing current limitations, challenges and future research ...
Tong Chen +13 more
wiley +1 more source
The echinocandins, caspofugin, micafungin, and anidulafungin, are lipopeptides that inhibit fungal growth by binding to β - (1.3) d glucan synthase. This enzyme is responsible for the formation of the peptidoglycan cell wall, and it is essential in fungi such as Candida spp, but less important in the case of Aspergillus and Fusarium species.
Jorge A, Cortés L, July A, Russi N
openaire +1 more source
Infeksi fungal invasif (IFI) masih menjadi penyebab utama morbiditas dan mortalitas pasien immunocompromised. Pilihan antifungal yang tersedia untuk IFI terbatas pada polyene, triazole, dan echinocandin.
Lukito, J. I. (Johan)
core

